Construction of a Nanodiamond–Tamoxifen Complex as a Breast Cancer Drug Delivery Vehicle
Open Access
- 27 October 2016
- journal article
- research article
- Published by Wiley in Journal of Nanomaterials
- Vol. 2016, 1-9
Abstract
According to the World Health Organization, breast cancer represents 16% of all cancer cases in women and is the second most common cancer. In the past decades, the mortality among patients with metastasis breast cancer has been reduced significantly via drug delivery by means of nanodiamond therapies, which are both biocompatible and scalable. In this study, we determined a theoretical pathway for the construction of a nanodiamond–tamoxifen complex that will act as a drug delivery vehicle for targeting tumor tissues of breast cancer. The tamoxifen pharmacophore was defined and the binding zone was identified for the electrostatic interaction between tamoxifen and a functionalized site of a nanodiamond particle allowing for attachment of the payload (this drug) to the surface of the nanodiamond particle. In addition, an analysis of the intermolecular interaction between the nanodiamond and tamoxifen was conducted, showing three hydrogen bonds complying fully with Lipinski’s rule of five, which states that a compound should have five or fewer hydrogen bonds to be permeating and easily absorbed by the body (qualitative prediction). All calculations were performed using the conceptual Density Functional Theory with the M06 functional and the basis set 6-31G(d). The solvent effect has been taken into account by an implicit model, the conductor like polarizable continuum model.Keywords
Funding Information
- Secretaría de Ciencia, Humanidades, Tecnología e Innovación
- Centro de Investigación de Materiales Avanzados
This publication has 60 references indexed in Scilit:
- Tamoxifen Treatment and the Reduced Risk of Hyperlipidemia in Asian Patients With Breast Cancer: A Population-Based Cohort StudyClinical Breast Cancer, 2015
- Nanomaterials in combating cancer: Therapeutic applications and developmentsNanomedicine: Nanotechnology, Biology and Medicine, 2014
- Profile of bazedoxifene/conjugated estrogens for the treatment of estrogen deficiency symptoms and osteoporosis in women at risk of fractureDrug Design, Development and Therapy, 2013
- Nanodiamonds as novel nanomaterials for biomedical applications: drug delivery and imaging systemsInternational Journal of Nanomedicine, 2013
- The Biocompatibility of Nanodiamonds and Their Application in Drug Delivery SystemsTheranostics, 2012
- Relevance of breast cancer hormone receptors and other factors to the efficacy of adjuvant tamoxifen: patient-level meta-analysis of randomised trialsThe Lancet, 2011
- Development of biodegradable polymer based tamoxifen citrate loaded nanoparticles and effect of some manufacturing process parameters on them: a physicochemical and in-vitro evaluationInternational Journal of Nanomedicine, 2010
- Targeting of tamoxifen to enhance antitumour action for the treatment and prevention of breast cancer: The ‘personalised’ approach?European Journal of Cancer, 2009
- Tamoxifen (ICI46,474) as a targeted therapy to treat and prevent breast cancerBritish Journal of Pharmacology, 2006
- Tamoxifen: a most unlikely pioneering medicineNature Reviews Drug Discovery, 2003